Wealthy actors’ aggressive adoption of IVF plus polygenic embryo selection (and potential future editing) will accelerate genetic stratification by making enhanced trait portfolios a transmissible form of elite advantage. As billionaire demand shapes supply (egg sourcing, clinic services, analytics), social inequality can become biologically entrenched within a generation unless access and regulation are changed.
— If true, the social and political stakes are vast: law on parentage and surrogacy, IVF regulation, equity in reproductive technology, and intergenerational inequality all become urgent national issues.
Johann Kurtz
2026.03.06
85% relevant
By describing affluent 'striver' families paying for unproven embryo selection to gain intelligence advantages, the article illustrates how paid embryo selection could concentrate biological advantage and reproduce elite advantage across generations.
2026.03.05
90% relevant
The article describes a private firm (Herasight) marketing embryo picks for higher predicted IQ and lower disease risk; that commercial deployment of polygenic prediction closely mirrors the concern that selecting embryos based on genomic scores will concentrate genetic advantages and amplify social inequality.
2026.03.05
80% relevant
By reporting companies offering trait predictions (IQ, height) and showing the scale of selectable differences across embryos, the article illuminates how commercial trait selection could create cumulative advantages for wealthier parents who can afford IVF and selection, matching the idea that chosen embryos can entrench genetic inequality.
2026.03.05
72% relevant
By casting GWAS-derived targets as a roadmap for ‘superhuman’ traits, the article implies easier selection or engineering of embryos, which connects to the risk that enhancement tools concentrate advantage and entrench social inequality.
2026.01.05
90% relevant
The article’s claim that 'the first babies artificially selected for greater intelligence have already been born' directly echoes the existing idea that wealthy adoption of embryo selection will entrench genetic advantage and create socio‑economic stratification; Palladium’s call to wake up aligns with warnings about inequality and the need for governance.
Steve Hsu
2026.01.01
100% relevant
Steve Hsu references 2025 breakthroughs in polygenic embryo screening and cites elite behavior (e.g., reports about Chinese billionaires' egg preferences) as evidence that high‑net‑worth individuals are already operationalizing these technologies.
2018.01.08
85% relevant
Plomin & von Stumm note that multipolygenic scores now explain a nontrivial share (>10%) of IQ variance, concretely increasing the feasibility and social stakes of embryo selection or other reproductive uses of PGS, thereby linking improved prediction to the risk of entrenching advantage.